Certain embodiments disclosed herein relate generally to a medical balloon, for example a medical cutting or serration balloon. Particular embodiments disclose features of a medical balloon such as an angioplasty balloon having adjustable outer dimensions, surface protrusions, and methods of controlled tearing of plaque during an angioplasty procedure.
Atherosclerotic occlusive disease is the primary cause of stroke, heart attack, limb loss, and death in the US and the industrialized world. Atherosclerotic plaque forms a hard layer along the wall of an artery and is comprised of calcium, cholesterol, compacted thrombus and cellular debris. As the atherosclerotic disease progresses, the blood supply intended to pass through a specific blood vessel is diminished or even prevented by the occlusive process. One of the most widely utilized methods of treating clinically significant atherosclerotic plaque is balloon angioplasty.
Balloon angioplasty is a method of opening blocked or narrowed blood vessels in the body. The balloon angioplasty catheter is placed into the artery from a remote access site that is created either percutaneously or through open exposure of the artery. The catheter is typically passed along the inside of the blood vessel over a wire that guides the way of the catheter. A portion of the catheter with a balloon attached is placed at the location of the atherosclerotic plaque that requires treatment. The balloon is inflated, generally to a size consistent with the original diameter of the artery prior to developing occlusive disease.
When the balloon is inflated, the plaque may be stretched, compressed, fractured, and/or broken, depending on its composition, location, and the amount of pressure exerted by the balloon. Plaque can be heterogeneous and may be soft in some areas or hard in others causing unpredictable cleavage planes to form under standard balloon angioplasty. Balloon angioplasty can cause plaque disruption and sometimes it causes arterial injury at the angioplasty site. There is a continuing need to improve the methods and systems for treating occlusive disease, including balloon angioplasty methods and systems.
A cutting or serration balloon can have a number of different components and can be made in a number of different manners. For example, one or more longitudinally extending members with periodic raised wedges can be attached to a medical balloon. They can be attached with a fiber coating, a polymer coating, or other methods. The fiber coating can be, for example, a thread or mesh that secures the longitudinally extending member to the balloon. In other embodiments, a polymer matrix can be used to bond the longitudinally extending member to the surface of the balloon. In some embodiments, the medical balloon can be an angioplasty balloon. In some embodiments, the medical balloon can be an off-the-shelf medical balloon, such as an off-the-shelf angioplasty balloon.
A serration balloon can comprise an off-the shelf medical balloon, such as an angioplasty balloon, with a plurality of cutting blades along a surface of the medical balloon. Each cutting blade of the plurality of cutting blades can comprise a strip of material with periodic raised wedges spaced along a length thereof. The plurality of cutting blades can be secured to balloon surface by a polymer matrix. The polymer matrix can be positioned between the plurality of cutting blades and the balloon surface, while also being around each of the plurality of cutting blades. The polymer matrix can be applied to the balloon prior to securing the plurality of cutting blades to the balloon and then the same polymer matrix can be reapplied to secure the plurality of cutting blades in place.
In some embodiments, each cutting blade of the plurality of cutting blades is a flat, planar piece of material that has the periodic raised wedges cut out along a length of the material. The flat, planar piece of material defining a primary plane, and the periodic raised wedges being in plane with the primary plane of the flat, planar piece of material. The plurality of cutting blades can be positioned along the surface of the medical balloon in the inflated state such that the primary plane is perpendicular to the surface of the medical balloon where it is attached. The flat, planar piece of material can not have a base or flange or other feature that extends outward from the side of the flat, planar piece of material. In addition, the periodic raised wedges can be solid and non-hollow (i.e. non-needle-like).
A method of manufacturing a serration balloon can comprise inflating a medical balloon, the medical balloon being on a catheter; dipping the medical balloon in the inflated state in a polymer matrix, such that the medical balloon has first layer of the polymer matrix; attaching a plurality of cutting blades along a surface of the medical balloon in the inflated state, each cutting blade of the plurality of cutting blades comprising a strip of material with periodic raised wedges spaced along a length thereof; and dipping the medical balloon in the inflated state with the attached plurality of cutting blades in the polymer matrix to form an over mold, such that at least a portion of each cutting blade of the plurality of cutting blades is sandwiched between the first layer of the polymer matrix and a second layer of the first polymer matrix.
A method of manufacturing a serration balloon can comprise inflating a medical balloon, the medical balloon being on a catheter; attaching a plurality of cutting blades along the surface of the medical balloon in the inflated state, each cutting blade of the plurality of cutting blades comprising a strip of material with periodic raised wedges spaced along a length thereof; and dipping the medical balloon in the inflated state with the attached plurality of cutting blades in a polymer matrix to form an over mold securing the plurality of cutting blades to the medical balloon.
A method of manufacturing a serration balloon can comprise inflating a medical balloon, the medical balloon being on a catheter; dipping the medical balloon in the inflated state in a polymer matrix to form a first layer of polymer matrix on an outer surface of the medical balloon; attaching a plurality of cutting blades to the first layer of polymer matrix along the surface of the medical balloon in the inflated state, each cutting blade of the plurality of cutting blades comprising a strip of material with periodic raised wedges spaced along a length thereof; and dipping the medical balloon in the inflated state with the attached plurality of cutting blades in the polymer matrix to form an over mold, a second layer of polymer matrix further securing the plurality of cutting blades to the first layer or polymer matrix and the medical balloon.
Various embodiments are depicted in the accompanying drawings for illustrative purposes, and should in no way be interpreted as limiting the scope of the inventions, in which like reference characters denote corresponding features consistently throughout similar embodiments.
Disclosed herein are various embodiments of systems and methods discussed primarily in the context of treating occlusive disease, including balloon angioplasty methods and systems. At the same time, it will be understood that the concepts and principles embodied in the various embodiments can also be used with other types of medical balloons, cutting balloons, and other types of medical procedures.
A cutting or serration balloon can have a number of different components and can be made in a number of different manners. For example, one or more longitudinally extending members with periodic raised wedges can be attached to a medical balloon. They can be attached with a fiber coating, a polymer coating, or other methods, various embodiments of which will be discussed below. The fiber coating can be, for example, a thread or mesh that secures the longitudinally extending member to the balloon. In other embodiments, a polymer matrix can be used to bond the longitudinally extending member to the surface of the balloon. In some embodiments, the medical balloon can be an angioplasty balloon. In some embodiments, the medical balloon can be an off-the-shelf medical balloon, such as an off-the-shelf angioplasty balloon.
In some embodiments the catheter can be a coaxial over-the-wire balloon catheter with a guidewire size compatibility of 0.018″. A high pressure (non-compliant/semi-compliant) trifold balloon can be made of nylon material with a diameter of 5 mm and a length of 20 mm±1 mm. The balloon has a nominal inflation pressure of 10 atm, a rated burst pressure of 22 atm, and an average burst pressure of 22 atm. The catheter working length is 110 cm±2 cm and has a tapered tip length of 3 mm±0.5 mm. Two standard radiopaque makers 42 are made up of 90% platinum and 10% iridium. The radiopaque markers 42 indicate the balloon working length. The inner shaft has a lubricious HDPE inner layer. The profile of the outer shaft is clear and 4.3FR (0.056 in ±0.0008 in; 1.42 mm±0.0200 mm.
The balloon 30 is disposed about the catheter 40 and is capable of being inflated. In some embodiments the balloon 30 is disposed about the distal end of the catheter 40 to be used in balloon angioplasty. In balloon angioplasty, the balloon can be inflated in order to mechanically widen or narrow obstructed arteries from plaque or other related deposits in the lumen of the blood vessel. As will be described below in more detail, structures can be attached to the surface of the balloon 30 that can be used to cut or score the plaque as the balloon 30 is expanded. Such an expansion opens up the blood vessel for improved flow. Subsequent to this procedure, the balloon 30 can be deflated and withdrawn from the body. In some embodiments, the balloon is a high pressure balloon. In some embodiments, the balloon 30 is made of nylon, has a diameter of 5 mm and can withstand a pressure of up to 22 atm.
Longitudinally extending members 20 can be positioned about the balloon 30. Each of the longitudinally extending members 20 include a plurality of periodic raised wedges 22 that are spaced apart by a plurality of grooves 24. The periodic raised wedges can have a height between 100 um to 500 um, more commonly between 150 um and 300 um, and frequently between 200 um and 250 um. The periodic raised wedges 22 extend longitudinally along the longitudinally extending members 20 each with a length that can be between 100 um to 1 mm, more commonly between 350 um and 750 um, and frequently between 400 um and 550 um. While the plurality of grooves 24 can extend longitudinally along the longitudinally extending members 20 each with a length that is between 1 times to 3 times the length of the periodic raised wedges 22, that can be between 100 um to 3 mm, more commonly between 350 um and 2 mm, and frequently between 800 um and 1.2 mm. In the illustrated embodiments, the longitudinally extending members 20 are strips of metal with rectangular shapes cut perpendicular to the length of the strips with a laser, EDM, grinding wheel, or similar to form the periodic raised wedges 22 and grooves 24. In some embodiments, the longitudinally extending members 20 can be in the form of strips, wires, ribbons, fibers, splines, etc. The periodic raised wedges 22 and grooves 24 can also vary in size and shape. In some embodiments, the periodic raised wedges 22 can have a height of 0.01 inches. In some embodiments, the periodic raised wedges 22 can be pointed, rounded, trapezoidal or can be shaped protrusions attached to the surface of the longitudinally extending members 20. The strips of metal can be flat, rounded, trapezoidal, or triangular in cross section.
The longitudinally extending members 20 can be attached to the balloon in a number of different ways. For example the longitudinally extending members 20 can be glued to the balloon. The longitudinally extending members 20 can be attached with a fiber, a polymer matrix, or other material.
In some embodiments, each longitudinally extending member 20 is a flat, planar piece of material that has the periodic raised wedges 22 cut out along a length of the material. The flat, planar piece of material defining a primary plane, and the periodic raised wedges being in plane with the primary plane of the flat, planar piece of material. The longitudinally extending members 20 can be positioned along the surface of the medical balloon in the inflated state such that the primary plane is perpendicular to the surface of the medical balloon where it is attached. For example, that longitudinally extending members 20 can be positioned to be aligned with the longitudinal axis of the catheter and the balloon. The flat, planar piece of material can not have a base or flange or other feature that extends outward from the side of the flat, planar piece of material. In addition, the periodic raised wedges can be solid and non-hollow (i.e. non-needle-like).
As shown in
The cutting balloon with fiber coating 200 can be created in a number of ways. For example in some embodiments, the balloon 30 is first brought to an expanded state. This can be done by inflating the balloon. Once the balloon 30 is expanded, the longitudinally extending members 20 are placed about the surface of the expanded balloon and secured to the balloon by the fiber 50. In the embodiment pictured in
A cutting balloon can include longitudinally extending members 20, balloon 30, catheter 40 and fiber 50 discussed above. In some embodiments, the balloon 30 is located on the distal end of the catheter 40. In some embodiments, the fiber 50 is only wrapped about the balloon 30 and spans from the proximal end of the balloon 30 to the distal end of the balloon 30.
In some embodiments, the cutting balloon has three longitudinally extending members 20 that are equally spaced radially around the balloon 30. The longitudinally extending members 20 can be attached to the flat surface of the balloon 30. The fiber 50 is a thread that is wrapped about the longitudinally extending members 20 and secures each of the longitudinally extending members 20 to the surface of the balloon 30 by securing the grooves 24 that are located between each of the periodic raised wedges 22 on the longitudinally extending members 20.
Once the cutting balloon with fiber coating 200 is inserted into the body of a patient and navigated to the target site, the balloon 30 can be expanded in a controlled fashion so that the longitudinally extending members 20 can be pushed against the walls of the lumen surface. The balloon 30 can be controllably inflated to increase its diameter. As the balloon 30 is inflated, the attached longitudinally extending members 20 are pushed outwards against the lumen. The periodic raised wedges 22 of the longitudinally extending members 20 can engage with the plaque in the lumen walls when the balloon 30 is expanded.
Other manufacturing methods can also be used. For example, the longitudinally extending members 20 can be sandwiched between two balloons. Such devices may or may not also include fibers 50. In another method, the longitudinally extending members 20 can be secured to the balloon during the balloon molding process. Further, the polymer material used to form the balloon can also be used to form the fiber 50. The balloon and fiber can be cured together with the longitudinally extending members 20 installed.
Turning now to
The balloon 30 can be dipped and then remain immersed in a solution for a given amount of time to allow a thin layer to deposit itself on the balloon. The balloon 30 with the coating can be allowed to drain and the solvent to evaporate. Then the balloon can be dipped again multiple times until an adequate layer is achieved. The longitudinally extending members 20 can then be attached to the balloon, followed by additional dipping into the polymer matrix. This can secure the longitudinally extending members 20 to the balloon with layers of the polymer matrix forming a strong bond to the balloon and the longitudinally extending members 20.
In some embodiments to aid the over mold in retention of the longitudinally extending members 20 to the balloon 30, the longitudinally extending members 20 can be dipped into the polymer matrix prior to attaching the longitudinally extending members 20 to the balloon. This may be in addition to or instead of bonding the longitudinally extending members 20 to the coated balloon with an adhesive material. Adhesive bonding to the coated balloon can be achieved with one or more points of attachment or along the entire length of the longitudinally extending members 20. After the longitudinally extending members 20 are affixed to the coated balloon surface a series of additional dips can be performed to achieve an affective retention layer. Since the longitudinally extending members 20 contain a series of recesses 24 between the periodic raised wedges 22 of metal, a backbone or strip of material can be identified offering a surface platform that the over mold or polymer coating can flow over and form a blanket or second layer of balloon to retain the longitudinally extending members 20.
Whether the additive material is fiber, mesh, dip/s, second balloon, or strip/s of material added to the outside of the balloon, the material on the outside of the balloon may be completely or selectively doped with a drug or STEM cell matrix through a series of surface ionic bonding manipulation. One such method of surface ionic bonding manipulation is performed by exposing the additive material to an environment with a selected ionic charge. Following selected ionic charging of the balloon surface the balloon can then be exposed to an alternate charge dopant filled environment to be adhered to the surface by ionic bonding energies. This process is repeatable until a suitable layer of desired dopant/s is achieved. A photolithographic process or other selective process such as templated assembly of selective removal may be employed.
The balloon 30 with the over mold can also be doped with a drug or STEM cell matrix through a series of surface ionic bonding manipulation. One such method of surface ionic bonding manipulation is performed by exposing the balloon 30 to an environment with a selected ionic charge. Following selected ionic charging of the balloon surface the balloon can then be exposed to an alternate charge dopant filled environment to be adhered to the surface by ionic bonding energies. This process is repeatable until a suitable layer of desired dopant/s is achieved.
A serration balloon can comprise an off-the shelf medical balloon, such as an angioplasty balloon, with a plurality of cutting blades along a surface of the medical balloon. Each cutting blade of the plurality of cutting blades can comprise a strip of material with periodic raised wedges spaced along a length thereof. The plurality of cutting blades can be secured to balloon surface by a polymer matrix. The polymer matrix can be positioned between the plurality of cutting blades and the balloon surface, while also being around each of the plurality of cutting blades. The polymer matrix can be applied to the balloon prior to securing the plurality of cutting blades to the balloon and then the same polymer matrix can be reapplied to secure the plurality of cutting blades in place.
A method of manufacturing a serration balloon can comprise inflating a medical balloon, the medical balloon being on a catheter; dipping the medical balloon in the inflated state in a polymer matrix, such that the medical balloon has first layer of the polymer matrix; attaching a plurality of cutting blades along a surface of the medical balloon in the inflated state, each cutting blade of the plurality of cutting blades comprising a strip of material with periodic raised wedges spaced along a length thereof; and dipping the medical balloon in the inflated state with the attached plurality of cutting blades in the polymer matrix to form an over mold, such that at least a portion of each cutting blade of the plurality of cutting blades is sandwiched between the first layer of the polymer matrix and a second layer of the first polymer matrix.
The method can further comprises applying an adhesive material to a bottom surface of each cutting blade of the plurality of cutting blades prior to attaching the plurality of cutting blades along the surface of the medical balloon. The method can further comprise dipping each cutting blade of the plurality of cutting blades into the polymer matrix prior to dipping the medical balloon with the attached plurality of cutting blades in the polymer matrix. Applying an adhesive material to a bottom surface of each cutting blade of the plurality of cutting blades prior to attaching the plurality of cutting blades along the surface of the medical balloon and after dipping each cutting blade of the plurality of cutting blades into the polymer matrix.
A method of manufacturing a serration balloon can comprise inflating a medical balloon, the medical balloon being on a catheter; attaching a plurality of cutting blades along the surface of the medical balloon in the inflated state, each cutting blade of the plurality of cutting blades comprising a strip of material with periodic raised wedges spaced along a length thereof; and dipping the medical balloon in the inflated state with the attached plurality of cutting blades in a polymer matrix to form an over mold securing the plurality of cutting blades to the medical balloon.
In some embodiments, the cutting blades can comprise strips of metal with a plurality of identical periodic raised wedges spaced along a length thereof, the periodic raised wedges not being hollow. The method can further comprise forming each cutting blade of the plurality of cutting blades from a flat, planar piece of material by cutting out the periodic raised wedges along a length of the material, the flat, planar piece of material defining a primary plane, and the periodic raised wedges being in plane with the primary plane of the flat, planar piece of material. Attaching the plurality of cutting blades along the surface of the medical balloon in the inflated state can further comprise attaching each cutting blade such that the primary plane is perpendicular to the surface of the medical balloon where it is attached. The flat, planar piece of material can not have a base or flange or other feature that extends outward from the side of the flat, planar piece of material.
A serration balloon can comprise an off-the shelf medical balloon, such as an angioplasty balloon, with a plurality of cutting blades along a surface of the medical balloon. Each cutting blade of the plurality of cutting blades can comprise a strip of material with periodic raised wedges spaced along a length thereof. The plurality of cutting blades can be secured to balloon surface by a polymer matrix. The polymer matrix can be positioned between the plurality of cutting blades and the balloon surface, while also being around each of the plurality of cutting blades. The polymer matrix can be applied to the balloon prior to securing the plurality of cutting blades to the balloon and then the same polymer matrix can be reapplied to secure the plurality of cutting blades in place.
In some embodiments, each cutting blade of the plurality of cutting blades is a flat, planar piece of material that has the periodic raised wedges cut out along a length of the material. The flat, planar piece of material defining a primary plane, and the periodic raised wedges being in plane with the primary plane of the flat, planar piece of material. The plurality of cutting blades can be positioned along the surface of the medical balloon in the inflated state such that the primary plane is perpendicular to the surface of the medical balloon where it is attached. The flat, planar piece of material can not have a base or flange or other feature that extends outward from the side of the flat, planar piece of material. In addition, the periodic raised wedges can be solid and non-hollow (i.e. non-needle-like).
A serration balloon can include an off-the shelf medical balloon; a plurality of cutting blades along a surface of the medical balloon, each cutting blade of the plurality of cutting blades comprising a strip of material with periodic raised wedges spaced along a length thereof; and a multi-layer polymer matrix, the plurality of cutting blades secured to the balloon surface by the multi-layer polymer matrix, the multi-layer polymer matrix positioned between the plurality of cutting blades and the balloon surface, while also being around each of the plurality of cutting blades. The polymer matrix can be applied to the balloon prior to securing the plurality of cutting blades to the balloon and then the same polymer matrix (or combination of polymer matrixes) can be reapplied to secure the plurality of cutting blades in place.
A benefit of the controlled balloon expansion system is it can allow for control of the angle of energy departed to the surface of the body lumen. According to some embodiments, this may be achieved through control of the depth of longitudinally extending members or the diameter at which the constrained balloon makes contact with the lumen wall. With a controlled depth of the longitudinally extending members, an angular depression can be generated along the lumen axis of the balloon that can apply a tangential force against the lumen wall at an angle of 45 degrees or less perpendicular to the lumen axis. At this angle the lumen tissue is susceptible to separating along the mid line of the depressed region. It can be noted that when attempting to tear a 2-D surface it is observed that an angle less than 90 degrees exists and offers greater control for predetermining the tear location and reduces the energy required to start and facilitate the continuation of a tear in the 2-D surface of many materials. When inducing expansion of arteries or other lumen tissue it is observed that the angle of energy departed at the lumen surface has an expansion effect at a similar angle to that as observed in the 2-D surface example. It has been observed that angles equal to or less than 45 degrees appear to have beneficial tearing effects on plaque in a blood vessel, although other predetermined angles may be used when tissue expansion is not the only desired effect.
Although this invention has been disclosed in the context of certain preferred embodiments and examples, it will be understood by those skilled in the art that the present invention extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the invention and obvious modifications and equivalents thereof. In addition, while a number of variations of the invention have been shown and described in detail, other modifications, which are within the scope of this invention, will be readily apparent to those of skill in the art based upon this disclosure. It is also contemplated that various combinations or sub-combinations of the specific features and aspects of the embodiments may be made and still fall within the scope of the invention. Accordingly, it should be understood that various features and aspects of the disclosed embodiments can be combined with or substituted for one another in order to form varying modes of the disclosed invention. Thus, it is intended that the scope of the present invention herein disclosed should not be limited by the particular disclosed embodiments described above, but should be determined only by a fair reading of the claims that follow.
Similarly, this method of disclosure, is not to be interpreted as reflecting an intention that any claim require more features than are expressly recited in that claim. Rather, as the following claims reflect, inventive aspects lie in a combination of fewer than all features of any single foregoing disclosed embodiment. Thus, the claims following the Detailed Description are hereby expressly incorporated into this Detailed Description, with each claim standing on its own as a separate embodiment.
This application is a continuation of U.S. patent application Ser. No. 16/680,135 filed on Nov. 11, 2019, which is a continuation of U.S. patent application Ser. No. 15/523,936 filed on May 2, 2017, which is the U.S. National Stage of PCT/US2015/058847 filed on Nov. 3, 2015, which in turn claims priority to U.S. Provisional App. No. 62/074,586 filed Nov. 3, 2014. All of the above application(s) is/are incorporated by reference herein in their entirety and are to be considered a part of this specification. Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference under 37 CFR 1.57.
Number | Name | Date | Kind |
---|---|---|---|
3221746 | Noble | Dec 1965 | A |
3635223 | Klieman | Jan 1972 | A |
4465072 | Taheri | Aug 1984 | A |
4665906 | Jervis | May 1987 | A |
4699611 | Bowden | Oct 1987 | A |
4795458 | Regan | Jan 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
5009659 | Hamlin | Apr 1991 | A |
5042707 | Taheri | Aug 1991 | A |
5078736 | Behl | Jan 1992 | A |
5192291 | Pannek, Jr. | Mar 1993 | A |
5196024 | Barath | Mar 1993 | A |
5209799 | Vigil | May 1993 | A |
5320634 | Vigil et al. | Jun 1994 | A |
5336234 | Vigil | Aug 1994 | A |
5397355 | Marin et al. | Mar 1995 | A |
5411478 | Stillabower | May 1995 | A |
5417707 | Parkola | May 1995 | A |
5423851 | Samuels | Jun 1995 | A |
5484411 | Inderbitzen et al. | Jan 1996 | A |
5501689 | Green | Mar 1996 | A |
5514154 | Lau et al. | May 1996 | A |
5569272 | Reed | Oct 1996 | A |
5591197 | Orth et al. | Jan 1997 | A |
5593434 | Williams | Jan 1997 | A |
5616149 | Barath | Apr 1997 | A |
5665116 | Chaisson | Sep 1997 | A |
5681346 | Orth | Oct 1997 | A |
5713860 | Kaplan et al. | Feb 1998 | A |
5713863 | Vigil et al. | Feb 1998 | A |
5718684 | Gupta | Feb 1998 | A |
5720726 | Marcadis et al. | Feb 1998 | A |
5797935 | Barath et al. | Aug 1998 | A |
5797951 | Mueller | Aug 1998 | A |
5800526 | Anderson | Sep 1998 | A |
5824053 | Khosravi et al. | Oct 1998 | A |
5868779 | Ruiz | Feb 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
6007543 | Ellis | Dec 1999 | A |
6036725 | Avellanet | Mar 2000 | A |
6048332 | Duffy et al. | Apr 2000 | A |
6053943 | Edwin | Apr 2000 | A |
6102904 | Vigil et al. | Aug 2000 | A |
6126685 | Lenker | Oct 2000 | A |
6197013 | Reed | Mar 2001 | B1 |
6221102 | Baker | Apr 2001 | B1 |
6254642 | Taylor | Jul 2001 | B1 |
6280414 | Shah et al. | Aug 2001 | B1 |
6290728 | Phelps | Sep 2001 | B1 |
6371962 | Ellis | Apr 2002 | B1 |
6450989 | Dubrul et al. | Sep 2002 | B2 |
6485496 | Suyker et al. | Oct 2002 | B1 |
6475237 | Drasler | Nov 2002 | B2 |
6562062 | Jenusaitis et al. | May 2003 | B2 |
6623452 | Chien et al. | Sep 2003 | B2 |
6626861 | Hart et al. | Sep 2003 | B1 |
6632231 | Radisch, Jr. | Oct 2003 | B2 |
6638246 | Naimark et al. | Oct 2003 | B1 |
6692504 | Kurz | Feb 2004 | B2 |
6719775 | Slaker | Apr 2004 | B2 |
6808518 | Wellman et al. | Oct 2004 | B2 |
6942680 | Grayzel et al. | Sep 2005 | B2 |
7007698 | Thornton | Mar 2006 | B2 |
7011670 | Radisch, Jr. | Mar 2006 | B2 |
7087088 | Berg | Aug 2006 | B2 |
7172609 | Radisch, Jr. | Feb 2007 | B2 |
7179284 | Khosravi | Feb 2007 | B2 |
7179345 | Shkolnik | Feb 2007 | B2 |
7186237 | Meyer et al. | Mar 2007 | B2 |
7204847 | Gambale | Apr 2007 | B1 |
7211101 | Carley | May 2007 | B2 |
7252674 | Wyzgala et al. | Aug 2007 | B2 |
7270673 | Yee | Sep 2007 | B2 |
7279002 | Shaw et al. | Oct 2007 | B2 |
7291158 | Crow | Nov 2007 | B2 |
7303572 | Meisheimer | Dec 2007 | B2 |
7326245 | Rosenthal et al. | Feb 2008 | B2 |
7331992 | Randall | Feb 2008 | B2 |
7413558 | Kelley et al. | Aug 2008 | B2 |
7500986 | Lye et al. | Mar 2009 | B2 |
7611484 | Wellman et al. | Nov 2009 | B2 |
7662163 | Grayzel et al. | Feb 2010 | B2 |
7686824 | Konstantino | Mar 2010 | B2 |
7691116 | Goodin | Apr 2010 | B2 |
7691119 | Farnan | Apr 2010 | B2 |
7771447 | Kunis | Aug 2010 | B2 |
7883537 | Grayzel et al. | Feb 2011 | B2 |
7931663 | Farnan | Apr 2011 | B2 |
7933660 | Carr | Apr 2011 | B2 |
7947015 | Herweck et al. | May 2011 | B2 |
7972351 | Trinidad | Jul 2011 | B2 |
7985234 | Wang et al. | Jul 2011 | B2 |
7993358 | O'Brien | Aug 2011 | B2 |
8002725 | Hogendijk | Aug 2011 | B2 |
8038691 | Bence et al. | Oct 2011 | B2 |
8052703 | St. Martin et al. | Nov 2011 | B2 |
8114049 | Freyman et al. | Feb 2012 | B2 |
8192675 | Burton et al. | Jun 2012 | B2 |
8211354 | Burton | Jul 2012 | B2 |
8323243 | Schneider et al. | Dec 2012 | B2 |
8361096 | Bence et al. | Jan 2013 | B2 |
8454637 | Aggerholm et al. | Jun 2013 | B2 |
8491615 | Manderfeld et al. | Jul 2013 | B2 |
8523887 | Grayzel et al. | Sep 2013 | B2 |
8557271 | Kimble et al. | Oct 2013 | B2 |
8574248 | Kassab | Nov 2013 | B2 |
8690903 | Bence et al. | Apr 2014 | B2 |
9017353 | Bence et al. | Apr 2015 | B2 |
9061127 | Weber et al. | Jun 2015 | B2 |
9066749 | Burton et al. | Jun 2015 | B2 |
9095688 | Burton | Aug 2015 | B2 |
9119944 | Chambers et al. | Sep 2015 | B2 |
9179936 | Feld et al. | Nov 2015 | B2 |
9199066 | Konstantino et al. | Dec 2015 | B2 |
9204893 | Rizk et al. | Dec 2015 | B2 |
9216033 | Feld et al. | Dec 2015 | B2 |
9226768 | Gunderson et al. | Jan 2016 | B2 |
9242076 | Burton et al. | Jan 2016 | B2 |
9302071 | Manderfeld et al. | Apr 2016 | B2 |
9320530 | Grace | Apr 2016 | B2 |
9339291 | Aggerholm et al. | May 2016 | B2 |
9393386 | Schneider et al. | Jul 2016 | B2 |
9415193 | Campbell et al. | Aug 2016 | B2 |
9480526 | Singh | Nov 2016 | B2 |
9480826 | Schneider et al. | Nov 2016 | B2 |
9586031 | Konstantino et al. | Mar 2017 | B2 |
9592119 | Tilson et al. | Mar 2017 | B2 |
9603619 | Bence et al. | Mar 2017 | B2 |
9604036 | Burton et al. | Mar 2017 | B2 |
10166374 | Giasolli et al. | Jan 2019 | B2 |
10172729 | Fulkerson et al. | Jan 2019 | B2 |
10258487 | Fulkerson et al. | Apr 2019 | B2 |
10300253 | Pederson | May 2019 | B2 |
10463842 | Giasolli et al. | Nov 2019 | B2 |
10471238 | Schneider et al. | Nov 2019 | B2 |
10689154 | Giasolli et al. | Jun 2020 | B2 |
10729892 | Yamazaki | Aug 2020 | B2 |
10905863 | Giasolli et al. | Feb 2021 | B2 |
11040178 | Schneider et al. | Jun 2021 | B2 |
11123527 | Giasolli et al. | Sep 2021 | B2 |
11141573 | Schneider et al. | Oct 2021 | B2 |
11166742 | Schneider et al. | Nov 2021 | B2 |
20010016726 | Dubrul et al. | Aug 2001 | A1 |
20010020151 | Reed et al. | Sep 2001 | A1 |
20020010489 | Grayzel et al. | Jan 2002 | A1 |
20020077594 | Chien et al. | Jun 2002 | A1 |
20030065303 | Wellman et al. | Apr 2003 | A1 |
20030153870 | Meyer et al. | Aug 2003 | A1 |
20030158595 | Randall | Aug 2003 | A1 |
20030163148 | Wang et al. | Aug 2003 | A1 |
20030229370 | Miller | Dec 2003 | A1 |
20040098014 | Flugelman et al. | May 2004 | A1 |
20040106904 | Gonnelli et al. | Jun 2004 | A1 |
20040143287 | Konstantino et al. | Jul 2004 | A1 |
20040158270 | Wyzgala et al. | Aug 2004 | A1 |
20040186551 | Kao | Sep 2004 | A1 |
20040249445 | Rosenthal et al. | Dec 2004 | A1 |
20050021070 | Feld et al. | Jan 2005 | A1 |
20050137618 | Kunis | Jun 2005 | A1 |
20050149082 | Yee et al. | Jul 2005 | A1 |
20050177130 | Konstantino et al. | Aug 2005 | A1 |
20050203388 | Carr | Sep 2005 | A1 |
20050228343 | Kelley | Oct 2005 | A1 |
20050251164 | Gifford | Nov 2005 | A1 |
20050267409 | Shkolnik | Dec 2005 | A1 |
20050288764 | Snow | Dec 2005 | A1 |
20060015134 | Trinidad | Jan 2006 | A1 |
20060085023 | Davies et al. | Apr 2006 | A1 |
20060122684 | Lye et al. | Jun 2006 | A1 |
20060129093 | Jackson | Jun 2006 | A1 |
20060184191 | Lye et al. | Jun 2006 | A1 |
20060149308 | Melsheimer | Jul 2006 | A1 |
20060271093 | Holman | Nov 2006 | A1 |
20070016232 | Martin et al. | Jan 2007 | A1 |
20070021774 | Hogendijk | Jan 2007 | A1 |
20070060863 | Goeken et al. | Mar 2007 | A1 |
20070093744 | Elmaleh | Apr 2007 | A1 |
20070191766 | McMorrow | Aug 2007 | A1 |
20070191811 | Berglund | Aug 2007 | A1 |
20070213761 | Murphy et al. | Sep 2007 | A1 |
20080015500 | Herweck et al. | Jan 2008 | A1 |
20080275483 | Makower et al. | Nov 2008 | A1 |
20090157159 | Schneider et al. | Jun 2009 | A1 |
20090214615 | Zhao | Aug 2009 | A1 |
20090227949 | Knapp et al. | Sep 2009 | A1 |
20100015196 | Kimble et al. | Jan 2010 | A1 |
20100042121 | Schneider et al. | Feb 2010 | A1 |
20100087783 | Weber et al. | Apr 2010 | A1 |
20100274188 | Chang et al. | Oct 2010 | A1 |
20100274271 | Kelly | Oct 2010 | A1 |
20110178503 | Kangas | Jul 2011 | A1 |
20110213401 | Grayzel et al. | Sep 2011 | A1 |
20120041412 | Roth et al. | Feb 2012 | A1 |
20120059401 | Konstantino et al. | Mar 2012 | A1 |
20120172901 | Manderfled et al. | Jul 2012 | A1 |
20120277843 | Weber et al. | Nov 2012 | A1 |
20130018396 | Gunderson et al. | Jan 2013 | A1 |
20130066346 | Pigott | Mar 2013 | A1 |
20130110142 | Bence et al. | May 2013 | A1 |
20130190725 | Pacetti et al. | Jul 2013 | A1 |
20130211381 | Feld | Aug 2013 | A1 |
20130218181 | Feld et al. | Aug 2013 | A1 |
20130253426 | Campbell et al. | Sep 2013 | A1 |
20130261545 | Osypka | Oct 2013 | A1 |
20140066898 | Cully et al. | Mar 2014 | A1 |
20140066960 | Feld et al. | Mar 2014 | A1 |
20160081711 | Gunderson et al. | Mar 2016 | A1 |
20160175568 | Manderfeld et al. | Jun 2016 | A1 |
20160324538 | Schneider et al. | Nov 2016 | A1 |
20160346506 | Jackson et al. | Dec 2016 | A1 |
20170106174 | Schneider et al. | Apr 2017 | A1 |
20170112526 | Burton et al. | Apr 2017 | A1 |
20170150988 | Konstantino et al. | Jun 2017 | A1 |
20180140804 | Tsukamoto et al. | May 2018 | A1 |
20180200491 | Giasolli et al. | Jul 2018 | A1 |
20180304052 | Schneider et al. | Oct 2018 | A1 |
20190240464 | Giasolli et al. | Aug 2019 | A1 |
20190262595 | Ryu et al. | Aug 2019 | A1 |
20190282789 | Mayda | Sep 2019 | A1 |
20200147355 | Schneider et al. | May 2020 | A1 |
20200155815 | Giasolli et al. | May 2020 | A1 |
20200188641 | Giasolli et al. | Jun 2020 | A1 |
20210213259 | Giasolli et al. | Jul 2021 | A1 |
20210353915 | Schneider et al. | Nov 2021 | A1 |
20210353916 | Giasolli et al. | Nov 2021 | A1 |
20210353917 | Schneider et al. | Nov 2021 | A1 |
20210353918 | Giasolli et al. | Nov 2021 | A1 |
20210353919 | Giasolli et al. | Nov 2021 | A1 |
Number | Date | Country |
---|---|---|
2009226025 | Sep 2009 | AU |
2015343272 | Jul 2020 | AU |
1642593 | Jul 2005 | CN |
101420913 | Mar 2012 | CN |
102512747 | Jun 2012 | CN |
102781508 | Nov 2012 | CN |
102939125 | Feb 2013 | CN |
203379465 | Jan 2014 | CN |
103582508 | Feb 2014 | CN |
103764218 | Apr 2014 | CN |
203564643 | Apr 2014 | CN |
103948972 | Jun 2016 | CN |
103930158 | Aug 2016 | CN |
107405158 | Nov 2017 | CN |
107405475 | Nov 2017 | CN |
108348734 | Jul 2018 | CN |
110114108 | Aug 2019 | CN |
ZL 201080051844.9 | Jul 2020 | CN |
ZL 201580071624.5 | Sep 2020 | CN |
1604704 | Dec 2005 | EP |
1809361 | Jul 2007 | EP |
2254641 | Sep 2016 | EP |
3215030 | Sep 2017 | EP |
3215212 | Sep 2017 | EP |
3349837 | Jul 2018 | EP |
3541464 | Sep 2019 | EP |
H05-293176 | Nov 1993 | JP |
H09-108358 | Apr 1997 | JP |
H09-192226 | Jul 1997 | JP |
2004-504111 | Feb 2004 | JP |
2006-501869 | Jan 2006 | JP |
2007-527740 | Oct 2007 | JP |
2008-519654 | Jun 2008 | JP |
2008-526312 | Jul 2008 | JP |
2008-529658 | Aug 2008 | JP |
WO 2002043796 | Jun 2002 | WO |
WO 2002078511 | Oct 2002 | WO |
WO 2003051442 | Jun 2003 | WO |
WO 2003068307 | Aug 2003 | WO |
WO 2003101310 | Dec 2003 | WO |
WO 2005076833 | Aug 2005 | WO |
WO 2006130194 | Dec 2006 | WO |
WO 2008020980 | Feb 2008 | WO |
WO 2009117158 | Sep 2009 | WO |
WO 2011035132 | Mar 2011 | WO |
WO 2013012714 | Jan 2013 | WO |
WO 2015187872 | Dec 2015 | WO |
WO 2016073490 | May 2016 | WO |
WO 2016073511 | May 2016 | WO |
WO 2016116821 | Jul 2016 | WO |
WO 2018094077 | May 2018 | WO |
WO 2020023749 | Jan 2020 | WO |
Entry |
---|
International Search Report and Written Opinion for International Application No. PCT/US2009/001786, dated Sep. 28, 2009 in 8 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2010/049297, dated Jun. 21, 2011 in 9 pages. |
Supplemental Search Report for European Application No. 09722111.3, dated Jun. 29, 2011 in 2 pages. |
Australian Office Action for Appliction No. 2009226025 dated Oct. 31, 2011 in 4 pages. |
Japanese Notice of Rejection in Japanese Patent Application 2011-500815 dated Jun. 26, 2012 in 7 pages. |
Japanese Notice of Rejection in Japanese Patent Application 2011-500815 dated Feb. 1, 2013 in 16 pages. |
Supplemental European Search Report for European Application No. 10817896.3 dated Jun. 19, 2013 in 8 pages. |
European Search Report dated Jun. 7, 2018 in EP application No. 15857951.6 in 7 pages. |
Supplemental Search Report for European Application No. 16847495, dated Apr. 30, 2019 in 9 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2019/043443, dated Oct. 1, 2019 in 14 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2015/034060, dated Nov. 5, 2015 in 23 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2015/058847, dated Feb. 23, 2016 in 12 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2015/058874, dated Mar. 30, 2016 in 22 pages. |
International Search Report for Application No. PCT/US2017/062060 dated Mar. 15, 2018 in 11 pages. |
European Extended Search Report dated Jun. 13, 2018 in EP application No. 15856760.2 in 9 pages. |
Office Action for Chinese Patent Application No. 201580071707.4 dated Jun. 28, 2019 in 8 pages. |
Australian Office Action for Application No. 2015343272 dated Jul. 24, 2019 in 4 pages. |
Australian Office Action for Application No. 2016324292 dated Jun. 1, 2020 in 6 pages. |
Office Action for Chinese Patent Application No. 201680059509.0 dated Jun. 2, 2020 in 21 pages. |
European Extended Search Report dated Jun. 17, 2020 in EP application No. 17872835.8 in 7 pages. |
Invitation to Pay Additional Search Fees in PCT Application No. PCT/US2021/071644, dated Dec. 2, 2021, in 3 pages. |
Number | Date | Country | |
---|---|---|---|
20210299418 A1 | Sep 2021 | US |
Number | Date | Country | |
---|---|---|---|
62074586 | Nov 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16680135 | Nov 2019 | US |
Child | 17320791 | US | |
Parent | 15523936 | US | |
Child | 16680135 | US |